| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3321 |
| Trial ID | NCT05702853 |
| Disease | B-Cell Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL |
| Year | 2023 |
| Country | United States |
| Company sponsor | Medical University of South Carolina |
| Other ID(s) | 103351 |
| Cohort 1 | |||||||||||
|
|||||||||||